# Bioequivalence Study of Klaribact 125mg/5ml, Suspension

> **NCT05340452** · NA · COMPLETED · sponsor: **University of Karachi** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Klaribact 125mg/5ml Suspension
- **DRUG:** Klaricid 125mg/5ml Suspension

## Key facts

- **NCT ID:** NCT05340452
- **Lead sponsor:** University of Karachi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-29
- **Primary completion:** 2013-07-08
- **Final completion:** 2013-10-25
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05340452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05340452, "Bioequivalence Study of Klaribact 125mg/5ml, Suspension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05340452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*